Is Pharma Ready to Disclose its Payments to Doctors in Europe?

Achieving the transparency demanded by the EFPIA Code on Disclosure of Transfers of Value to healthcare professionals and healthcare organizations promises to present major complexity—especially since each of the 33 countries involved has its own approach to complying with the regulation. Pharmaphorum editor, Andrew McConagahie explores how companies are preparing to manage this technical challenge and the cultural shift. Read the full story.